These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 20656380)
1. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444 [TBL] [Abstract][Full Text] [Related]
3. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Zarranz B; Jaso A; Aldana I; Monge A Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents. Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298 [TBL] [Abstract][Full Text] [Related]
6. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide. Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199 [TBL] [Abstract][Full Text] [Related]
8. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones. Ramalingam P; Ganapaty S; Rao ChB Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Sriram D; Yogeeswari P; Devakaram RV Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M; Bakken V; Gundersen LL Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890 [TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583 [TBL] [Abstract][Full Text] [Related]
13. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents. Bacelar AH; Carvalho MA; Proença MF Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides. Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794 [TBL] [Abstract][Full Text] [Related]
17. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR. Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446 [TBL] [Abstract][Full Text] [Related]
18. Novel dihydropyrimidines as a potential new class of antitubercular agents. Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]